PNC Financial Services Group’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$43 4902
2024
Q4
$43 Hold
1
﹤0.01% 4739
2024
Q3
$128 Hold
1
﹤0.01% 4711
2024
Q2
$100 Sell
1
-10
-91% -$1.19K ﹤0.01% 4716
2024
Q1
$1.97K Buy
11
+10
+1,000% +$1.24K ﹤0.01% 4196
2023
Q4
$180 Buy
+1
New +$87 ﹤0.01% 4493

Other funds holding BCAB

PNC Financial Services Group's BCAB Position: Q1 2025 in Review

PNC Financial Services Group sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 1 share — an estimated $43 sold.

PNC Financial Services Group first reported a position in BCAB in Q4 2023 and held it in 5 quarters. The position peaked at $1.97K in Q1 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • PNC Financial Services Group reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 1 BioAtla share in Q1 2025, an estimated $43.
  • PNC Financial Services Group first reported a position in BioAtla in Q4 2023 and held it in 5 quarters.
  • PNC Financial Services Group's BioAtla position peaked at $1.97K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on PNC Financial Services Group's 13F filing for Q1 2025, filed 9 May 2025.